Inhibrx Biosciences

Cash burn rate (est.)	Burn method: Change in cash	Burn method: Operating income	Burn method: FCF (opex + capex)
Cash on hand (at last report)	196.33 mm	196.33 mm	196.33 mm
Cash burn (monthly)	10.18 mm	15.60 mm	(no burn)
Cash used (since last report)	42.10 mm	64.54 mm	n/a
Cash remaining	154.23 mm	131.79 mm	n/a
Runway (months of cash)	15.2	8.4	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2024

Inhibrx Biosciences institutional ownership history Ownership history

74.8% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	100	88	+13.6%
Opened positions	24	88	-72.7%
Closed positions	12	0	NEW
Increased positions	34	0	NEW
Reduced positions	17	0	NEW

13F shares	Current	Prev Q	Change
Total value	136.98 bn	135.67 bn	+1.0%
Total shares	10.83 mm	11.57 mm	-6.4%
Total puts	79.40 k	107.73 k	-26.3%
Total calls	223.74 k	155.68 k	+43.7%
Total put/call ratio	0.4	0.7	-48.7%

Largest owners	Shares	Value	Change
Viking Global Investors	1.79 mm	$28.00 bn	0.0%
SNY Sanofi	1.16 mm	$0.00	0.0%
Perceptive Advisors	1.06 mm	$16.66 bn	0.0%
Jon Faiz Kayyem	806.08 k	$27.50 mm	0.0%
BlackRock	717.15 k	$11.23 bn	NEW
Walleye Capital	550.00 k	$8.61 bn	+15.8%
Sofinnova Investments	536.07 k	$8.39 bn	+15.7%
Vanguard	530.06 k	$8.30 bn	+10.9%
Slotnik Capital	369.35 k	$5.78 bn	+8.1%
Millennium Management	289.36 k	$4.53 bn	-4.6%

Largest transactions	Shares	Bought/sold	Change
BlackRock	717.15 k	+717.15 k	NEW
BLK BlackRock	0.00	-683.08 k	EXIT
Alpine Associates Management	0.00	-305.97 k	EXIT
TIG Advisors	0.00	-243.65 k	EXIT
Ikarian Capital	42.12 k	-187.88 k	-81.7%
Tang Capital Management	0.00	-167.50 k	EXIT
MMCAP International Inc. SPC	0.00	-112.86 k	EXIT
Marshall Wace	90.65 k	-106.85 k	-54.1%
Soleus Capital Management	0.00	-88.47 k	EXIT
Walleye Capital	550.00 k	+75.00 k	+15.8%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

Inhibrx Biosciences insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
16 Dec 24	Jon Faiz Kayyem	Common Stock	Gift	Acquire G	Yes	No	0	250,000	0.00	250,000
16 Dec 24	Jon Faiz Kayyem	Common Stock	Gift	Acquire G	Yes	No	0	250,000	0.00	250,000
16 Dec 24	Jon Faiz Kayyem	Common Stock	Gift	Dispose G	Yes	No	0	500,000	0.00	509,360
6 Dec 24	Jon Faiz Kayyem	Common Stock	Gift	Dispose G	Yes	No	0	52,000	0.00	1,009,360
20 Nov 24	Jon Faiz Kayyem	Common Stock	Buy	Acquire P	Yes	No	14.1921	18,750	266.10 k	69,843
20 Nov 24	Jon Faiz Kayyem	Common Stock	Buy	Acquire P	Yes	No	14.1921	18,750	266.10 k	69,843
19 Nov 24	Jon Faiz Kayyem	Common Stock	Buy	Acquire P	Yes	No	14.2269	34,843	495.71 k	51,093
19 Nov 24	Jon Faiz Kayyem	Common Stock	Buy	Acquire P	Yes	No	14.2269	34,843	495.71 k	51,093
3 Oct 24	Vuori Kristiina MD	Common Stock	Buy	Acquire P	No	No	15	6,667	100.01 k	20,443
16 Sep 24	Mark Lappe	Common Stock	Buy	Acquire P	Yes	No	17.13	13,037	223.32 k	705,548

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.